Acceleron Pharma Inc.
Methods for treating ulcers in a hemoglobinopathy anemia with a soluble actRIIB polypeptide
Last updated:
Abstract:
The present disclosure provides compositions and methods for treating or preventing ulcers in subjects having low red blood cell levels and/or hemoglobin levels (e.g, anemia). In some embodiments, the compositions of the disclosure may be used to treat or prevent ulcers associated with anemia.
Status:
Grant
Type:
Utility
Filling date:
21 Nov 2017
Issue date:
26 Nov 2019